David J Tate

Dr. David J Tate

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
DTDavid J Tate
David J Tate
LDLobke Desomer
Lobke Desomer
HAHalim Awadie
Halim Awadie
KGKathleen Goodrick
Kathleen Goodrick
LHLuke Hourigan
Luke Hourigan
MBMichael J. Bourke
Michael J. Bourke

1 September 2019 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
DTDavid J Tate
David J Tate
AKAmir Klein
Amir Klein
MSMayenaaz Sidhu
Mayenaaz Sidhu
LDLobke Desomer
Lobke Desomer
HAHalim Awadie
Halim Awadie
MBMichael J. Bourke
Michael J. Bourke

6 July 2023 in Gut
Verified
Journal Article
Closed access
PDF file
DTDavid J Tate
David J Tate
LDLobke Desomer
Lobke Desomer
Maria Eva ArgenzianoMaria Eva Argenziano
Maria Eva Argenziano
NMNeha Mahajan
Neha Mahajan
MSMayenaaz Sidhu
Mayenaaz Sidhu
MBMichael J Bourke
Michael J Bourke
Objective Residual or recurrent adenoma (RRA) after endoscopic mucosal resection (EMR) of large non-pedunculated colorectal polyps (LNPCPs) of ≥20 mm is a major limitation. Data on outcomes of the endoscopic treatment of recurrence are scarce, and no evidence-based standard exists. We investigated the efficacy of endoscopic retreatment over time in a large prospective cohort. Design Over 139 months, detailed morphological and histological data on consecutive RRA detected after EMR for single LNPCPs at one tertiary endoscopy centre were prospectively recorded during structured surveillance colonoscopy. Endoscopic retreatment was performed on cases with evidence of RRA and was performed predominantly using hot snare resection, cold avulsion forceps with adjuvant snare tip soft coagulation or a combination of the two. Results 213 (14.6%) patients had RRA (168 (78.9%) at first surveillance and 45 (21.1%) thereafter). RRA was commonly 2.5–5.0 mm (48.0%) and unifocal (78.7%). Of 202 (94.8%) cases which had macroscopic evidence of RRA, 194 (96.0%) underwent successful endoscopic therapy and 161 (83.4%) had a subsequent follow-up colonoscopy. Of the latter, endoscopic therapy of recurrence was successful in 149 (92.5%) of 161 in the per-protocol analysis, and 149 (73.8%) of 202 in the intention-to-treat analysis, with a mean of 1.15 (SD 0.36) retreatment sessions. No adverse events were directly attributable to endoscopic therapy. Further RRA after endoscopic therapy was endoscopically treatable in most cases. Overall, only 9 (4.2%, 95% CI 2.2% to 7.8%) of 213 patients with RRA required surgery. Thus 159 (98.8%, 95% CI 95.1% to 99.8%) of 161 cases with initially successful endoscopic treatment of RRA and follow-up remained surgery-free for a median of 13 months (IQR 25.0) of follow-up. Conclusions RRA after EMR of LNPCPs can be effectively treated using simple endoscopic techniques with long-term adenoma remission of >90%; only 16% required retreatment. Therefore, more technically complex, morbid and resource-intensive endoscopic or surgical techniques are required only in selected cases. Trial registration numbers NCT01368289 and NCT02000141

1 January 1997 in Current Eye Research
Verified
Journal Article
Closed access
DTDavid J Tate
David J Tate
MMMichael V. Miceli
Michael V. Miceli
DNDavid A. Newsome
David A. Newsome
PURPOSE. We have previously shown that an experimental, low-zinc environment decreased catalase activity in cultured human fetal retinal pigment epithelial (RPE) cells. The purpose of this study was to investigate the effect of zinc supplementation on catalase expression in cultured human fetal RPE cells. METHODS. Confluent fetal RPE cells incubated in Coon's modified Ham's F12 (CMF-12) were treated (18 h) with zinc chloride (ZnCl 2) (15, 30, or 100 µM) to assess changes in catalase enzyme activity or for 6 h to assess the induction of catalase mRNA by Northern analysis and in situ hybridization. RPE cells were also treated with 30 µM ZnCl 2 for 2, 6, 24, 48 and 72 h to assess the time course of changes in catalase enzyme activity, changes in mRNA levels and status of the Sp1 transcription factor. RESULTS. Catalase activity was increased above control by the addition of 15, 30 and 100 µM ZnCl 2. Catalase gene expression was induced by 30 µM zinc in 6 h, but decreased to non-treated control levels by 24 h....

14 June 2024 in Gut
Verified
Journal Article
Open access
PDF file
PSPieter Sinonquel
Pieter Sinonquel
TETom Eelbode
Tom Eelbode
OPOliver Pech
Oliver Pech
DWDominiek De Wulf
Dominiek De Wulf
PDPieter Dewint
Pieter Dewint
RBRaf Bisschops
Raf Bisschops
Background and aim Randomised trials show improved polyp detection with computer-aided detection (CADe), mostly of small lesions. However, operator and selection bias may affect CADe’s true benefit. Clinical outcomes of increased detection have not yet been fully elucidated. Methods In this multicentre trial, CADe combining convolutional and recurrent neural networks was used for polyp detection. Blinded endoscopists were monitored in real time by a second observer with CADe access. CADe detections prompted reinspection. Adenoma detection rates (ADR) and polyp detection rates were measured prestudy and poststudy. Histological assessments were done by independent histopathologists. The primary outcome compared polyp detection between endoscopists and CADe. Results In 946 patients (51.9% male, mean age 64), a total of 2141 polyps were identified, including 989 adenomas. CADe was not superior to human polyp detection (sensitivity 94.6% vs 96.0%) but outperformed them when restricted to adenomas. Unblinding led to an additional yield of 86 true positive polyp detections (1.1% ADR increase per patient; 73.8% were <5 mm). CADe also increased non-neoplastic polyp detection by an absolute value of 4.9% of the cases (1.8% increase of entire polyp load). Procedure time increased with 6.6±6.5 min (+42.6%). In 22/946 patients, the additional detection of adenomas changed surveillance intervals (2.3%), mostly by increasing the number of small adenomas beyond the cut-off. Conclusion Even if CADe appears to be slightly more sensitive than human endoscopists, the additional gain in ADR was minimal and follow-up intervals rarely changed. Additional inspection of non-neoplastic lesions was increased, adding to the inspection and/or polypectomy workload.

11 July 2022 in Endoscopy
Verified
Journal Article
Closed access
PDF file
MMMichael Xiang Ma
Michael Xiang Ma
DTDavid J Tate
David J Tate
MSMayenaaz Sidhu
Mayenaaz Sidhu
SZSimmi Zahid
Simmi Zahid
MBMichael J. Bourke
Michael J. Bourke
Background Pre-resection biopsy (PRB) of large nonpedunculated colorectal polyps (LNPCPs, ≥ 20 mm) is often performed before referral for endoscopic mucosal resection (EMR). How this affects the EMR procedure is unknown. Methods This was a retrospective analysis of a prospectively collected cohort of patients with LNPCPs referred for EMR between 2013 to 2016 at an Australian tertiary center. Outcomes were differences between PRB and EMR histology, and effects of PRB on the EMR procedure. Results Among 586 LNPCPs, lesions that underwent PRB were larger (median 35 vs. 30 mm; P < 0.007), and more commonly morphologically flat or slightly elevated (P = 0.01) compared with lesions without PRB. PRB histology was upstaged in 26.1 %, downstaged in 13.8 %, and unchanged in 60.1 % after EMR. Sensitivity of PRB was 77.2 % (95 %CI 71.1–82.4) for low grade dysplasia (LGD) and 21.2 % (95 %CI 11.5–35.1) for high grade dysplasia (HGD). Where EMR specimen showed HGD, PRB had detected LGD in 76.9 %. Where EMR specimen showed cancer, PRB had detected dysplasia only. PRB was associated with more submucosal fibrosis (P = 0.001) and intraprocedural bleeding (P = 0.03). EMR success or recurrence was not affected. Conclusions Routine PRB of LNPCP did not reliably detect advanced histology and may have affected EMR complexity. PRB should be utilized with caution in guiding endoscopic management of LNPCPs.